Cargando…

Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis

The off-label use of bevacizumab labeled with 99mTc as a new radiopharmaceutical for imaging of endometriosis is a promising noninvasive, new clinical procedure. The bevacizumab in monoclonal antibodies targeted at vascular endothelial growth factor (VEGF) is superexpressed in cases of endometriosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Daniel Escorsim, Perini, Jamila Alessandra, Orlando, Margarida Maria Camoes, Santos-Oliveira, Ralph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512512/ https://www.ncbi.nlm.nih.gov/pubmed/26240826 http://dx.doi.org/10.1155/2015/751460

Ejemplares similares

CYP2C19 metabolic estrogen phenotypes and endometriosis risk in Brazilian women
por: Perini, Jamila Alessandra, et al.
Publicado: (2023)

Combined Effect of the PGR +331C > T, CYP17A1 -34A > G and CYP19A1 1531G > A Polymorphisms on the Risk of Developing Endometriosis
por: Cardoso, Jéssica Vilarinho, et al.
Publicado: (2017)

Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis
por: Machado, Daniel Escorsim, et al.
Publicado: (2016)

Anticancer potential, molecular mechanisms and toxicity of Euterpe oleracea extract (açaí): A systematic review
por: Alessandra-Perini, Jéssica, et al.
Publicado: (2018)

Role of vascular endothelial growth factor polymorphisms (-2578C > A, -460 T > C, -1154G > A, +405G > C and +936C > T) in endometriosis: a case–control study with Brazilians
por: Perini, Jamila Alessandra, et al.
Publicado: (2014)

Topical application of Acheflan on rat skin injury accelerates wound healing: a histopathological, immunohistochemical and biochemical study
por: Perini, Jamila Alessandra, et al.
Publicado: (2015)

Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab
por: Muñoz-Villegas, Patricia, et al.
Publicado: (2021)

Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab
por: Nugue, Guillaume, et al.
Publicado: (2013)

Euterpe oleracea extract (açaí) exhibits cardioprotective effects after chemotherapy treatment in a breast cancer model
por: Alessandra-Perini, Jéssica, et al.
Publicado: (2023)

Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response
por: Silva, Tábata Almeida, et al.
Publicado: (2022)

Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis
por: Acimovic, Milena, et al.
Publicado: (2016)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014)

Wound Healing Activity and Chemical Standardization of Eugenia pruniformis Cambess
por: de Albuquerque, Ricardo Diego Duarte Galhardo, et al.
Publicado: (2016)

Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
por: Rusovici, Raluca, et al.
Publicado: (2011)

Does anti-VEGF bevacizumab improve survival in experimental sepsis?
por: Besnier, Emmanuel, et al.
Publicado: (2017)

Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer
por: Alessandra-Perini, Jéssica, et al.
Publicado: (2018)

Fc receptor-like 3 (−169T>C) polymorphism increases the risk of tendinopathy in volleyball athletes: a case control study
por: Salles, José Inácio, et al.
Publicado: (2018)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance
por: Alidzanovic, Lejla, et al.
Publicado: (2016)

Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives
por: Anastasiu, Costin Vlad, et al.
Publicado: (2020)

Vascular Endothelial Growth Factor Receptor-2 Polymorphisms Have Protective Effect against the Development of Tendinopathy in Volleyball Athletes
por: Salles, José Inácio, et al.
Publicado: (2016)

Bevacizumab: Off-label use in ophthalmology
por: Grisanti, Salvatore, et al.
Publicado: (2007)

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody
por: Fushida, Sachio, et al.
Publicado: (2013)

Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF
por: Sharma, Rajesh K., et al.
Publicado: (2010)

Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab
por: Latzer, Pauline, et al.
Publicado: (2016)

Blocking VEGF by Bevacizumab Compromises Electrophysiological and Morphological Properties of Hippocampal Neurons
por: Latzer, Pauline, et al.
Publicado: (2019)

Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus
por: Liu, Xiaochun, et al.
Publicado: (2016)

A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
por: Soysal, D, et al.
Publicado: (2015)

Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
por: Jun, Jong Hwa, et al.
Publicado: (2016)

Matrix metalloproteinases 3 polymorphism increases the risk of developing advanced endometriosis and infertility: A case-control study
por: Cardoso, Jéssica V, et al.
Publicado: (2019)

Immunocytochemical Labelling of Haematological Samples Using Monoclonal Antibodies
por: Erber, Wendy N.
Publicado: (2021)

Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies
por: Méndez-Valdés, Gabriel, et al.
Publicado: (2023)

Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation
por: Starlinger, P, et al.
Publicado: (2012)

A pharmacokinetic binding model for bevacizumab and VEGF(165) in colorectal cancer patients
por: Panoilia, Eirini, et al.
Publicado: (2015)

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients
por: Ding, Yi, et al.
Publicado: (2022)

Technological Advancements in Monoclonal Antibodies
por: Santos-Neto, José F., et al.
Publicado: (2021)

COVID-19 Coronavirus-Induced Atypical Pneumonia: Efficacy of the Monoclonal Antibody Bevacizumab in Moderate to Severe Cases
por: Patel, Greshaben, et al.
Publicado: (2021)

Dehiscence of colorectal anastomosis treated with noninvasive procedures
por: Cwaliński, Jarosław, et al.
Publicado: (2022)

An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics
por: Bernardini, Roberto, et al.
Publicado: (2022)

Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye
por: Jiang, Xiaodan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8ca6fj85r9tlgtkdc9bvb3hm3r